The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics
Open accessAbstract
Abstract Pharmaceutical industry and the art and science of drug development are sorely in need of novel transformative technologies in the current age of digital health and artificial intelligence (AI). Often described as game-changing technologies, AI and machine learning algorithms have slowly but surely begun to revolutionize pharmaceutical industry and drug development over the past 5 years. In this expert review, we describe the most frequently used machine learning algorithms in drug development pipelines and the -omics databases well poised to support machine learning and drug discovery. Subsequently, we analyze the emerging new computational approaches to drug discovery and the in silico pipelines for drug repositioning and the synergies among -omics system sciences, AI and machine learning. As with system sciences, AI and machine learning embody a system scale and Big Data driven vision for drug discovery and development. We conclude with a future outlook on the ways in which machine learning approaches can be implemented to buttress and expedite drug discovery and precision medicine. As AI and machine learning are rapidly entering pharmaceutical industry and the art and science of drug development, we need to critically examine the attendant prospects and challenges to benefit patients and public health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many more examples are available [3,32,33,34,35,36,37], showing that AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Mining association rules between sets of items in large databases
Agrawal, R., Imieliński, T., & Swami, A. (1993) · ACM SIGMOD Record · doi:10.1145/170036.170072 · Cited by 4,551
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1951 · Cited by 2,673
Bias in error estimation when using cross-validation for model selection
Varma, S., & Simon, R. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-91 · Cited by 2,485 · cited 1×
“Then, the procedure is repeated as many times as the data points (Baek et al., 2009; Varma and Simon, 2006).”
Machine learning applications in genetics and genomics
Libbrecht, M. W., & Noble, W. S. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3920 · Cited by 2,250
Assessing the accuracy of prediction algorithms for classification: an overview
Baldi, P., Brunak, S., Chauvin, Y., Andersen, C. A. F., & Nielsen, H. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.5.412 · Cited by 2,111
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Hoadley, K. A., Yau, C. S. F., Wolf, D. M., Cherniack, A. D., Tamborero, D., Ng, S., Leiserson, M. D. M., Niu, B., McLellan, M. D., Uzunangelov, V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.049 · Cited by 1,537
Deep learning for computational biology
Angermueller, C., Pärnamaa, T., Parts, L., & Stegle, O. (2016) · Molecular Systems Biology · doi:10.15252/msb.20156651 · Cited by 1,473
Cohen, J., Pertsemlidis, A., Kotowski, I. K., Graham, R., Garcia, C. K., & Hobbs, H. H. (2005) · Nature Genetics · doi:10.1038/ng1509 · Cited by 1,381
Byers, L. A., Diao, L., Wang, J., Saintigny, P., Girard, L., Peyton, M., Shen, L., Fan, Y., Giri, U., Tumula, P. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1558 · Cited by 1,059
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
Geeleher, P., Cox, N. J., & Huang, R. S. (2014) · Genome biology · doi:10.1186/gb-2014-15-3-r47 · Cited by 897
A community effort to assess and improve drug sensitivity prediction algorithms
Community, N. D., Costello, J. C., Heiser, L. M., Georgii, E., Gönen, M., Menden, M. P., Wang, N. J., Bansal, M., Ammad-ud-din, M., Hintsanen, P., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2877 · Cited by 782
Review of Drug Repositioning Approaches and Resources
Xue, H., Li, J., Xie, H., & Wang, Y. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24612 · Cited by 613
Menden, M. P., Iorio, F., Garnett, M. J., McDermott, U., Benes, C. H., Ballester, P. J., & Sáez-Rodríguez, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061318 · Cited by 543
Nicolau, M. M., Levine, A. J., & Carlsson, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102826108 · Cited by 516
Loss-of-function mutations in SLC30A8 protect against type 2 diabetes
Go-T2D Consortium, Flannick, J., T2D-GENES Consortium, Thorleifsson, G., Beer, N. L., Jacobs, S. B. R., Grarup, N., Burtt, N. P., Mahajan, A., Fuchsberger, C., et al. (2014) · Nature Genetics · doi:10.1038/ng.2915 · Cited by 492
Pharmacogenomic agreement between two cancer cell line data sets
The Cancer Cell Line Encyclopedia Consortium, & The Genomics of Drug Sensitivity in Cancer Consortium (2015) · Nature · doi:10.1038/nature15736 · Cited by 418
Gönen, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts360 · Cited by 383
Drug repositioning: a machine-learning approach through data integration
Napolitano, F., Zhao, Y., Moreira, V. M., Tagliaferri, R., Kere, J., D’Amato, M., & Greco, D. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-30 · Cited by 349
A review of network-based approaches to drug repositioning
Lotfi Shahreza, M., Ghadiri, N., Mousavi, S. R., Varshosaz, J., & Green, J. R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbx017 · Cited by 330
A community computational challenge to predict the activity of pairs of compounds
Community, N.-D., Bansal, M., Yang, J., Karan, C., Menden, M. P., Costello, J. C., Tang, H., Xiao, G., Li, Y., Allen, J., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3052 · Cited by 321
Zhu, T., Cao, S., Su, P.-C., Patel, R., Shah, D., Chokshi, H. B., Szukala, R., Johnson, M. E., & Hevener, K. E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301916b · Cited by 321
A review of computational drug repurposing
Park, K. (2019) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2019.27.2.59 · Cited by 314
Global Proteome Analysis of the NCI-60 Cell Line Panel
Gholami, A. M., Hahne, H., Wu, Z., Auer, F. J., Meng, C., Wilhelm, M., & Kuster, B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.018 · Cited by 302
Modeling precision treatment of breast cancer
Daemen, A., Griffith, O. L., Heiser, L. M., Wang, N. J., Enache, O. M., Sanborn, Z., Pepin, F., Durinck, S., Korkola, J. E., Griffith, M., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-10-r110 · Cited by 291
Frismantas, V., Dobay, M. P., Rinaldi, A. M., Tchinda, J., Dunn, S. H., Kunz, J. B., Richter‐Pechańska, P., Marovca, B., Pail, O., Jenni, S., et al. (2017) · Blood · doi:10.1182/blood-2016-09-738070 · Cited by 266
Manifold alignment using Procrustes analysis
Wang, C., & Mahadevan, S. (2008) · International Conference on Machine Learning · doi:10.1145/1390156.1390297 · Cited by 265
Weeber, M., Klein, H., den Berg, L. T. W. D. J., & Vos, R. (2001) · Journal of the American Society for Information Science and Technology · doi:10.1002/asi.1104 · Cited by 265
The Next Era: Deep Learning in Pharmaceutical Research
Ekins, S. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2029-7 · Cited by 249
Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
Emig, D., Ivliev, A. E., Pustovalova, O., Lancashire, L., Bureeva, S. V., Nikolsky, Y., & Bessarabova, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060618 · Cited by 242
Biomarkers as drug development tools: discovery, validation, qualification and use
Kraus, V. B. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0005-9 · Cited by 231
Mamoshina, P., Volosnikova, M., Ozerov, I. V., Lane, E., Skibina, E., Cortese, F., & Zhavoronkov, A. A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00242 · Cited by 231
Ding, M. Q., Chen, L., Cooper, G. F., Young, J. D., & Lu, X. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0378 · Cited by 195
A multi-scale convolutional neural network for phenotyping high-content cellular images
Godinez, W. J., Hossain, I., Lazic, S. E., Davies, J. W., & Zhang, X. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx069 · Cited by 189
Predicting in vitro drug sensitivity using Random Forests
Riddick, G., Song, H., Ahn, S. J., Walling, J., Borges-Rivera, D., Zhang, W., & Fine, H. A. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq628 · Cited by 170
Ten things we have to do to achieve precision medicine
Kohane, I. S. (2015) · Science · doi:10.1126/science.aab1328 · Cited by 164
Network-based drug repositioning
Wu, Z., Wang, Y., & Chen, L. (2013) · Molecular BioSystems · doi:10.1039/c3mb25382a · Cited by 162
A Study on the Application and Use of Artificial Intelligence to Support Drug Development
Lamberti, M. J., Wilkinson, M., Donzanti, B. A., Wohlhieter, G. E., Parikh, S., Wilkins, R. G., & Getz, K. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.05.018 · Cited by 160
Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening
Tyner, J. W., Yang, W. F., Bankhead, A., Fan, G., Fletcher, L. B., Bryant, J. A., Glover, J., Chang, B. H., Spurgeon, S. E. F., Fleming, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1906 · Cited by 148
Geeleher, P., Zhang, Z., Wang, F., Gruener, R. F., Nath, A., Morrison, G., Bhutra, S., Grossman, R. L., & Huang, R. S. (2017) · Genome Research · doi:10.1101/gr.221077.117 · Cited by 142
Caveats and pitfalls of ROC analysis in clinical microarray research (and how to avoid them)
Berrar, D., & Flach, P. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbr008 · Cited by 136 · cited 1×
“Similarly, the most common metrics are correlations for regression-based models, are the root-mean-squared errors, and the coefficient of determination (Baldi et al., 2000; Berrar and Flach, 2012).”
In silico prediction of novel therapeutic targets using gene–disease association data
Ferrero, E., Dunham, I., & Sanséau, P. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1285-6 · Cited by 134
Vougas, K. N., Sakellaropoulos, T., Kotsinas, A., Foukas, G.-R. P., Ntargaras, A., Koinis, F., Polyzos, A., Myrianthopoulos, V., Zhou, H., Narang, S., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107395 · Cited by 129
Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel
Cortés‐Ciriano, I., van Westen, G. J. P., Bouvier, G., Nilges, M., Overington, J. P., Bender, A., & Malliavin, T. E. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv529 · Cited by 123
Ammad-ud-din, M., Khan, S. A., Malani, D., Murumägi, A., Kallioniemi, O., Aittokallio, T. A., & Samuel Kaski, A. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw433 · Cited by 116
Interaction prediction in structure-based virtual screening using deep learning
Gonczarek, A., Tomczak, J. M., Zaręba, S., Kaczmar-Michalska, J., Dąbrowski, P., & Walczak, M. (2017) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2017.09.007 · Cited by 105
Andersson, E. I., Pützer, S., Yadav, B., Dufva, O., Khan, S., He, L., Sellner, L., Schrader, A., Crispatzu, G., Oleś, M., et al. (2017) · Leukemia · doi:10.1038/leu.2017.252 · Cited by 94
An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge
Wan, Q., & Pal, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101183 · Cited by 85
Chen, B., Sirota, M., Fan-Minogue, H., Hadley, D., & Butte, A. J. (2015) · BMC Medical Genomics · doi:10.1186/1755-8794-8-s2-s5 · Cited by 80
Aben, N., Vis, D. J., Michaut, M., & Wessels, L. F. A. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw449 · Cited by 75
Ammad-ud-din, M., Khan, S. A., Wennerberg, K., & Aittokallio, T. A. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx266 · Cited by 73
Heterogeneity Aware Random Forest for Drug Sensitivity Prediction
Rahman, R., Matlock, K., Ghosh, S., & Pal, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11665-4 · Cited by 71
Gene expression profile alone is inadequate in predicting complete response in multiple myeloma
Amin, S. B., Yip, W.-K., Minvielle, S., Broyl, A., Li, Y., Hanlon, B. M., Swanson, D. M., Shah, P. K., Moreau, P., van der Holt, B., et al. (2014) · Leukemia · doi:10.1038/leu.2014.140 · Cited by 61
Falgreen, S., Dybkær, K., Young, K. H., Xu-Monette, Z. Y., El‐Galaly, T. C., Laursen, M. B., Bødker, J. S., Kjeldsen, M. K., Schmitz, A., Nyegaard, M., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1237-6 · Cited by 59
Ali, M., Khan, S. A., Wennerberg, K., & Aittokallio, T. A. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx766 · Cited by 59
Development of biomarker classifiers from high-dimensional data
Baek, S., Tsai, C., & Chen, J. J. (2009) · Briefings in Bioinformatics · doi:10.1093/bib/bbp016 · Cited by 56
Ли, Б., Shin, H., Gulbekyan, G., Pustovalova, O., Nikolsky, Y., Hope, A. J., Bessarabova, M., Schu, M. C., Kolpakova-Hart, E., Merberg, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130700 · Cited by 53
Pathway and network-based strategies to translate genetic discoveries into effective therapies
Greene, C. S., & Voight, B. F. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw160 · Cited by 52
Structure-Based Functional Design of Drugs: From Target to Lead Compound
Anderson, A. C. (2011) · Methods in molecular biology · doi:10.1007/978-1-60327-216-2_23 · Cited by 51
Computational identification of multi-omic correlates of anticancer therapeutic response
Stetson, L. C., Pearl, T., Chen, Y., & Barnholtz-Sloan, J. S. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s7-s2 · Cited by 49
Linking drug target and pathway activation for effective therapy using multi-task learning
Yang, M., Simm, J., Lam, C. C., Zakeri, P., van Westen, G. J. P., Moreau, Y., & Sáez-Rodríguez, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25947-y · Cited by 46
Turki, T., Wei, Z., & Wang, J. T. L. (2018) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720018400140 · Cited by 40
DIGRE: Drug‐Induced Genomic Residual Effect Model for Successful Prediction of Multidrug Effects
Yang, J., Tang, J. P., Li, Y., Zhong, R., Wang, T.-M., Wong, S. T. C., Xiao, G., & Xie, Y. (2015) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.1 · Cited by 37
A tool for discovering drug sensitivity and gene expression associations in cancer cells
Qin, Y. W., Conley, A. P., Grimm, E. A., & Roszik, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176763 · Cited by 34
Robust Prediction of Anti-Cancer Drug Sensitivity and Sensitivity-Specific Biomarker
Park, H., Shimamura, T., Miyano, S., & Imoto, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108990 · Cited by 22
A p-Median approach for predicting drug response in tumour cells
Fersini, E., Messina, E., & Archetti, F. (2014) · BMC Bioinformatics · doi:10.1186/s12859-014-0353-7 · Cited by 20
Tran, T. P., Ong, E., Hodges, A. P., Paternostro, G., & Piermarocchi, C. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-74 · Cited by 19
Garvey, C. K. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0218 · Cited by 10
Research works printed but not linked: 7
- Azuaje F. (2017). Computational models for predicting drug responses in cancer research. Brief Bioinform, 18, 820–829.
- Jang IS, , Neto EC, , Guinney J, , Friend SH, , and Margolin AA. (2014). Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data. Pac Symp Biocomput, 2014:63–74.
- Kuo M.-H, , Kushniruk A, , Borycki EM, , and Greig D. (2009). Application of the Apriori algorithm for adverse drug reaction detection. Stud Health Technol Inform, 148, 95–101.
- Neto EC, , Jang IS, , Friend S. H, , and Margolin AA. (2014). The Stream algorithm: Computationally efficient ridge-regression via Bayesian model averaging, and applications to pharmacogenomic prediction of cancer cell line sensitivity. Pac Symp Biocomput, 2014, 27–38.
- Nguyen L, , Dang C, , and Ballester PJ. (2016). Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression data. F1000Research, 5, ISCB Comm. J-2927.
- Zhao K, , and So H. (2017). A machine learning approach to drug repositioning based on drug expression profiles: Applications to schizophrenia and depression/anxiety disorders. arXiv
- Zou J, , Zheng M.-W, , Li G, , and Su Z.-G. (2013). Advanced systems biology methods in drug discovery and translational biomedicine. Biomed Res Int, 2013, 1–8. · DOI
Cited by
Sorted by citations
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
The role of AI in drug discovery: challenges, opportunities, and strategies
Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690
Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development
Sarkar, C., Das, B., Rawat, V. S., Wahlang, J. B., Nongpiur, A., Tiewsoh, I., Lyngdoh, N. M., Das, D., Bidarolli, M., & Sony, H. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032026 · Cited by 347
Artificial intelligence, machine learning, and drug repurposing in cancer
Tanoli, Z., Vähä-Koskela, M. J. V., & Aittokallio, T. A. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1883585 · Cited by 229
Selvaraj, C., Chandra, I., & Singh, S. K. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10326-z · Cited by 220
Metadata
- Authors
- Koromina, M., Pandi, M.-T., & Patrinos, G. P.
- Affiliations
- University of Patras (GR)
- Corresponding author
- Patrinos, George P.
- Venue
- OMICS A Journal of Integrative Biology
- Publisher
- SAGE Publications
- Published
- 2019-11
- Volume
- 23
- Issue
- 11
- Pages
- 539-548
- ISSN
- 1536-2310 (ISSN-L)
- 1557-8100
- OpenAlex
- W2981458781
- Cited by
- 140
- References
- 74
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 25 · 2023: 23 · 2022: 21 · 2021: 16 · 2020: 13
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- OMICS A Journal of Integrative Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Keywords
- drug repurposing, drug development, artificial intelligence, machine learning, omics databases, computational drug discovery, precision medicine, big data, pharmaceutical industry
- MeSH terms
- Machine Learning, Algorithms, Artificial Intelligence, Models, Theoretical, Reproducibility of Results, Computational Biology, Genomics, Drug Discovery, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
